Neurocrine Biosciences Q1 Earnings Update
Neurocrine Biosciences has released its first quarter 2025 financial results. As of the latest available data, the company’s stock closed at $101.38 USD.
Key Financial Metrics
- The stock has reached a 52-week high of $157.98 USD on July 31, 2024.
- The 52-week low was $84.23 USD on April 8, 2025.
Valuation Metrics
- Price-to-earnings ratio: 27.56
- Price-to-book ratio: 3.48